Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: My recommendation in case of the futur PTSC strategy to the BOD/CEO:

No DIVIDENDS CASH is KING hold all the cash for right acquisition (s). The RIGHT thing to do.

Share
New Message
Please login to post a reply